PUBLICATIONS & PATENTS

Lanier OL, Cisernos E, Morse B, Malik K, Peppas NA (2024). Sex-based Differences in Nanoparticle Response in Primary Human Macrophages. Advanced NanoBioMed Research. In preparation.

 

Lanier OL, Al Buzz R, Morse B, Peppas NA (2024). Adjusting the Size of Cationic Nanoparticles for Increased Uptake by Human Macrophages. J of Applied Polymer Science. In preparation.

 

Lanier OL, Krishnan N, Peppas NA (2024). Fine-tuning Hydrogel Properties: Exploring Multifaceted Monomer Compositions for Drug Delivery. J of Applied Polymer Science. In preparation.

 

Lanier OL, Cisernos E, Malik K, Morse B, Peppas NA (2024). The Effects of Patient Characteristics on Protein Corona Formation and Nanoparticle Fate: Toward Tailored Nanomedicines. Advanced Drug Delivery Reviews. In preparation.

 

Bahrami K, Lee E, Morse B, Lanier OL, Peppas NA (2023). Design of nanoparticle-based systems for the systemic delivery of chemotherapeutics: Alternative potential routes via sublingual and buccal administration for systemic drug delivery. Drug Delivery and Translational Research, https://doi.org/10.1007/s13346-023-01493-7.

 

Lanier OL, D’Andrea A, Shodeinde A, Peppas NA (2023). siRNA Delivery from Cationic Nanogels Prepared by Diffusion-assisted Loading in the Presence and Absence of Electrostatic Interactions, J of Applied Polymer Science, e55029.

 

Coolich-Kanzelberger M, Lanier OL, Cisneros E, Peppas NA (2023). PEGylated Insulin Loaded Complexation Hydrogels for Protected Oral Delivery, Journal of Controlled Release, 364: 216-226.

 

Pérez-Herrero E, Lanier OL, Krishnan N, D’Andrea A, Peppas NA (2023). Drug Delivery Approaches for Cancer Immunotherapy, Drug Delivery and Translational Research, 1-32.

 

Shodeinde A, Lanier OL, Nallaparaju S, Lam M, Savk A, Peppas NA (2023). Tuning the pH-Responsive Properties of (2-Diisopropylamino) Ethyl Methacrylate-Based Cationic Nanoparticles: Towards Enhanced Nanoparticle Stability and Cytocompatibility, Biomedical Materials & Devices, 1-12.

 

Cisneros E, Sherwani N, Lanier OL, Peppas NA (2023). Targeted Delivery Methods for RNA Interference Are Necessary to Obtain a Potential Functional Cure for HIV/AIDS, Advanced Drug Delivery Reviews, 114970.

 

Lanier OL*, Pérez-Herrero E*, D’Andrea AP, Bahrami K, Lee E, Ward DM,  Ayala-Suárez N, Rodríguez-Méndez SM, Peppas NA (2022). Immunotherapy Approaches for Hematological Cancers, iScience, 25 (11), 105326.

 

Lanier OL*, Green M*, Barabino G, Cosgriff-Hernandez E. (2022). 10 Rules for Engineers to Improve Health Equity, PLOS Computational Biology, 18(10), e1010525.

 

Peppas, NA, Lanier, OL (2022). Replacing Injections with Oral Medications: Hydrogels Move Medical Treatments Home, American Scientist, 110, 202-203.

 

Liu, W, Wang Y, Wang J, Lanier OL, Wechsler ME, Peppas NA, Gu Z (2022). Macroencapsulation Devices for Cell Therapy, Engineering, 13: 53-70.

 

Lanier OL, Manfre M, Kulkarni S, Bailey C, Chauhan A (2021). Combining Modeling of Drug Uptake and Release of Cyclosporine in Contact Lenses to Determine Partition Coefficient and Diffusivity, European Journal of Pharmaceutical Sciences, 164: 105891.  

 

Lanier OL, Manfre M, Bailey C, Liu Z, Sparks Z, Kulkarni S, Chauhan A (2021). Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations, AAPS PharmSciTech, 22(3): 1-16.

 

Liu Z, Lanier OL, Chauhan A (2020). PVA Assisted Synthesis and Anti-Solvent Precipitation of Gold Nanoparticles, Nanomaterials, 10(12): 2359.

 

Lanier OL, Ficarrotta J, Adjei I, Wable D, Lewis C, Nacea C, Sharma B, Dobson, McFetrdige, PS (2020). Magnetically Responsive Polymeric Microparticles for the Triggered Delivery of a Complex Mixture of Human Placental Proteins. Macromolecular Biosciences, 20(1): 2000249

 

Lanier OL, Velez C, Arnold DP, Dobson J (2020). Magnetic Particle Capture Device Model for Removal of Pro-Inflammatory Cytokines During Cardiopulmonary Bypass. IEEE Transactions on BME, 68(4): 1198-1207.

 

Lanier OL, Christopher K, Macoon R,  Sakar P, Chauhan A (2020). Commercialization Challenges of Drug Eluting Contact Lenses. Expert Opinions on Drug Delivery, 17(8): 1133-1149.

 

Lanier OL, Korotych OI, Monsalve AG, Wable D, Savliwala S, Grooms NWF, Nacea C, Tuitt OR, Dobson J. (2019). Evaluation of Magnetic Nanoparticles for Magnetic Fluid Hyperthermia. Int J of Hyperthermia, 36(1): 687-701.

 

Lanier OL, McFetridge PS, Dobson J. Magnetically Responsive Composite Microparticles for Triggered Delivery of Biologically Active Agents, and Methods and Systems for Magnetically Triggered Delivery of Biologically Active Agents. PCT Patent Application PCT/US2019/056740, filed October 17, 2019.

 

Lanier, OL, Monsalve, AG., McFetridge, PS., Dobson, J. (2018). Magnetically Triggered Release of Biologics. International Materials Reviews. 64: 63-90.

 

Noori MS, O’Brien JD, Champa ZJ, Deosarkar, SP, Lanier OL, Qi C, Burdick MM, Schwartz FL, Bergmeier SC, McCall KD, Goetz DJ. (2017). Phenylmethimazole and a Thiazole Derivative of Phenylmethimazole Inhibit IL-6 Expression by Triple Negative Breast Cancer Cells. Eur. J. Pharmacol., 803: 130–137.

 

Alapati A, Deosarkar SP, Lanier OL, Qi C, Carlson GE, Burdick MM, Schwartz FL, McCall KD, Bergmeier SC, Goetz DJ. (2015). Simple Modifications to Methimazole that Enhance its Inhibitory Effect on Tumor Necrosis Factor-α-Induced Vascular Cell Adhesion Molecule-1 Expression by Human Endothelial Cells. Eur J Pharmacol., 751: 59-66.